E-LIB Suche - Ergebnisse für: Tod, A.M.

1

Suboptimal exposure to fluconazole in critically ill patien..:

Bienvenu, A.L. ; Pradat, P. ; Matusik, E....
Infectious Diseases Now. 53 (2023) 2 - p. 104630 , 2023

Link: https://doi.org/10.1016/..

2

Coût des antibiothérapies hors AMM dans les infections osté..:

Pham, T. ; Mabrut, E. ; Cochard, P....
Infectious Diseases Now. 51 (2021) 5 - p. S95 , 2021

Link: https://doi.org/10.1016/..

3

Preponderant impact of the chemosensitivity assessed by the..:

You, B. ; Tod, M. ; Leary, A....
Gynecologic Oncology. 159 (2020) - p. 339-340 , 2020

Link: https://doi.org/10.1016/..

4

Thesaurus for off-label indications for systemic antifungal..:

Bienvenu, A.L. ; Aussedat, M. ; Maldonado, F....
Médecine et Maladies Infectieuses. 49 (2019) 4 - p. 275-280 , 2019

Link: https://doi.org/10.1016/..

5

MesoTRAP: A feasibility study comparing video-assisted thor..:

Rintoul, R.C. ; Maskell, N. ; Edwards, J.G....
Lung Cancer. 115 (2018) - p. S89 , 2018

Link: https://doi.org/10.1016/..

6

Patient experience of extended pleurectomy decortication (E..:

Tod, A.M. ; Lord, K. ; Warnock, C...
Lung Cancer. 115 (2018) - p. S82-S83 , 2018

Link: https://doi.org/10.1016/..

7

96: An evaluation of a lung cancer research training for nu..:

Tod, A.M. ; Magee, L. ; Coates, M...
Lung Cancer. 103 (2017) - p. S44 , 2017

Link: https://doi.org/10.1016/..

8

Coût des antibiothérapies hors AMM dans les infections osté..:

Mabrut, E. ; Cochard, P. ; Chardon, P....
Médecine et Maladies Infectieuses. 47 (2017) 4 - p. S86 , 2017

Link: https://doi.org/10.1016/..

9

162: Receiving a diagnosis of mesothelioma: Improving the p..:

Tod, A.M. ; Warnock, C. ; Stanley, H....
Lung Cancer. 103 (2017) - p. S74 , 2017

Link: https://doi.org/10.1016/..

10

Quantitative Prediction of Drug-Drug Interactions Involving..:

Tod, M ; Goutelle, S ; Bourguignon, L.
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 4 - p. 226-226 , 2017

Link: https://doi.org/10.1002/..

11

Evènements indésirables (EI) de l'antibiothérapie probabili..:

Triffault-Fillit, C. ; Valour, F. ; Tod, M....
Médecine et Maladies Infectieuses. 47 (2017) 4 - p. S14-S15 , 2017

Link: https://doi.org/10.1016/..

12

A Model for Predicting the Interindividual Variability of D..:

Tod, M. ; Bourguignon, L. ; Bleyzac, N..
The AAPS Journal. 19 (2016) 2 - p. 497-509 , 2016

Link: https://doi.org/10.1208/..

13

102: Prospective assessment of incident respiratory symptom..:

Brummell, S. ; Tod, A.M. ; Rogers, T...
Lung Cancer. 87 (2015) - p. S38 , 2015

Link: https://doi.org/10.1016/..

14

Modeling and predicting optimal treatment scheduling betwee..:

Wilson, S ; Tod, M ; Ouerdani, A...
CPT: Pharmacometrics & Systems Pharmacology. 4 (2015) 12 - p. 720-727 , 2015

Link: https://doi.org/10.1002/..

15

A Joint Model for the Kinetics of CTC Count and PSA Concent..:

Wilbaux, M ; Tod, M ; De Bono, J...
CPT: Pharmacometrics & Systems Pharmacology. 4 (2015) 5 - p. 277-285 , 2015

Link: https://doi.org/10.1002/..